Citius Pharmaceuticals Inc share price logo

Citius Pharmaceuticals Inc Share Price

NASDAQ: CTXR

Small Cap

$1.21

+0.01

(+0.83%)

as on

Citius Pharmaceuticals Inc Stock Performance

as on September 13, 2025 at 1:29 am IST

  • Day's Low

    $1.18
    $1.21
    downward going graph

    2.48%

    Downside

  • 52 Week's Low

    52 Week's High

    $0.65
    $15.25
    downward going graph

    46.28%

    Downside

    1160.33%

    Upside

    downward going graph

Citius Pharmaceuticals Inc share price movements today

Previous Close
$1.20
Open
$1.20
Volume
426.7K
Day's Low - High
$1.18 - $1.21
52 Week Low - High
$0.65 - $15.25

Citius Pharmaceuticals Inc Historical Returns

1 Month Return
-6.25 %
3 Month Return
+ 37.21 %
1 Year Return
-90.77 %
3 Year Return
-96.25 %
5 Year Return
-95.25 %

Citius Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Citius Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$20.4M

EPS (TTM)

-2.08

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

P/B Ratio

0

PEG Ratio

0

EBITDA

-41.1M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

15051100.00%

Citius Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Citius Pharmaceuticals Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$20.4M-95.25%NA0.00%
BUY$61.1B280.5%-505.15-12.96%
NA$37.7BNANA-3.89%
BUY$101.2B54.04%28.0831.86%
BUY$59.4B2.03%14.1131.37%

Stock Returns calculator for Citius Pharmaceuticals Inc Stock including INR - Dollar returns

The Citius Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Citius Pharmaceuticals Inc investment value today

Current value as on today

₹14,447

Returns

₹85,553

(-85.55%)

Returns from Citius Pharmaceuticals Inc Stock

₹90,692 (-90.69%)

Dollar Returns*

₹5,139 (+5.14%)

Analyst Recommendation on Citius Pharmaceuticals Inc Stock

Based on 9 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for Citius Pharmaceuticals Inc. Average target price of $6

Citius Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on Citius Pharmaceuticals Inc.

What analysts predicted

79.83%UPSIDE

Target Price

$6

Current Price

$1.21

Analyzed by

9 Analysts

Target

$6.00

Citius Pharmaceuticals Inc target price $6, a slight upside of 79.83% compared to current price of $1.21. According to 9 analysts rating.

Citius Pharmaceuticals Inc Stock's Interest Amongst Investors

Search interest for Citius Pharmaceuticals Inc Stock has increased by 5% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:5% versus previous 30 day period

Citius Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
-
-
-
-
-
-
-
0
-
-
Gross Profit
0
0
0
0
0
0
-
0
0
0
Operating Income
-10
-8
-10
-9
-10
-10
-11
-10
-11
-8
EBITDA
-10
-8
-10
-9
-10
-10
-10
-9
-11
-8
Interest Expense
0
-
4
-
-
-
-
-
-
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-10
-8
-9
-9
-8
-10
-10
-10
-11
-8
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-10
-8
-9
-9
-8
-10
-10
-9
-11
-8
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
-6264.67%
0.00%
0.00%

Citius Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

Sep 2015
Sep 2016
Sep 2017
Sep 2018
Sep 2019
Sep 2020
Sep 2021
Sep 2022
Sep 2023
Sep 2024
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
0
0
0
0
0
0
0
0
0
Operating Income
-3
-7
-9
-13
-15
-17
-23
-33
-36
-41
EBITDA
-3
-7
-9
-13
-15
-17
-22
-32
-31
-38
Interest Expense
0
0
0
0
0
0
0
0
-
-
Depreciation
-
-
0
0
0
0
0
0
0
0
Income Before Tax
-2
-8
-10
-12
-15
-17
-23
-33
-31
-38
Income Tax Expense
0
0
0
1
0
0
0
0
0
0
Net Income
-2
-8
-10
-12
-15
-17
-23
-33
-32
-39
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Citius Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-8
-9
-9
-8
-10
-11
-10
-11
-8
Operating Cash Flow
-9
-6
-6
-7
-8
-5
-4
-4
-5
Investing Cash Flow
-
-
-
-
-
-
-5
-
-
Financing Cash Flow
13
0
-
-
13
-3
2
3
11
Change in Cash
4
-6
-6
-7
5
-14
-2
-1
6

Citius Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

Sep 2016
Sep 2017
Sep 2018
Sep 2019
Sep 2020
Sep 2021
Sep 2022
Sep 2023
Sep 2024
Net Income
-8
-10
-12
-15
-17
-23
-33
-32
-39
Operating Cash Flow
-5
-7
-11
-12
-16
-24
-28
-29
-28
Investing Cash Flow
0
0
0
0
0
-40
-
-
-5
Financing Cash Flow
5
10
17
11
22
120
0
13
9
Change in Cash
0
2
5
-1
5
56
-28
-15
-23

Global Institutional Holdings in Citius Pharmaceuticals Inc

Funds
Holdings
Vanguard Group Inc
2.31%
CAMBRIDGE Invest RESEARCH ADVISORS, INC.
1.64%
Geode Capital Management, LLC
0.8%
BlackRock Inc
0.65%
UBS Group AG
0.6%

Insights on Citius Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 125.6% return, outperforming this stock by 221.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.7% return, outperforming this stock by 166.5%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 year, CTXR stock has moved down by -90.8%

About Citius Pharmaceuticals Inc

citius pharmaceuticals, inc., a specialty pharmaceutical company, develops and commercializes critical care products. it primarily focuses on developing anti-infective, cancer care, prescription, and mesenchymal stem cell therapy products. the company is developing mino-lok, an antibiotic lock solution used to treat patients with catheter-related bloodstream infections by salvaging the infected catheter, which is in phase iii clinical trials; mino-wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; halo-lido, a corticosteroid-lidocaine topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; and novecite, a mesenchymal stem cell therapy for the treatment of acute respiratory disease syndrome. citius pharmaceuticals, inc. was founded in 2007 and is headquartered in cranford, new jersey.
OrganisationCitius Pharmaceuticals Inc
Headquarters11 Commerce Drive, Cranford, NJ, United States, 07016
IndustryHealth Technology
CEOMr. Leonard L. Mazur
E-voting on sharesClick here to vote

Key Management of Citius Pharmaceuticals Inc

Name

Title

Mr. Myron Z. Holubiak

Co-Founder & Executive Vice Chairman

Dr. Alan Lader Ph.D.

Senior VP and Head of Clinical Operations & Quality Assurance

Mr. Dhananjay G. Wadekar

Senior Vice President of Business Strategy

Mr. Nikolas Burlew

Executive Vice President of Quality Assurance

Mr. Leonard L. Mazur

Co-Founder, CEO, Chairman & Secretary

Mr. Jaime Bartushak

Chief Business Officer & CFO

Mr. Gary F. Talarico

Executive Vice President of Operations

Ms. Ilanit Allen

Vice President of Investor Relations & Corporate Communications

Dr. Myron S. Czuczman M.D.

Executive VP & Chief Medical Officer

Mr. Kelly Creighton Ph.D.

Executive Vice President of Chemistry, Manufacturing & Controls

FAQs

What is Citius Pharmaceuticals Inc share price today?

Citius Pharmaceuticals Inc share price today is $1.21 as on at the close of the market. Citius Pharmaceuticals Inc share today touched a day high of $1.21 and a low of $1.18.

What is the 52 week high and 52 week low for Citius Pharmaceuticals Inc share?

Citius Pharmaceuticals Inc share touched a 52 week high of $15.25 on and a 52 week low of $0.65 on . Citius Pharmaceuticals Inc stock price today i.e. is closed at $1.21,which is 92.07% down from its 52 week high and 86.15% up from its 52 week low.

What is Citius Pharmaceuticals Inc's market capitalisation today?

Citius Pharmaceuticals Inc market capitalisation is $0.00T as on .

How to invest in Citius Pharmaceuticals Inc Stock (CTXR) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Citius Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Citius Pharmaceuticals Inc Shares that will get you 1.2397 shares as per Citius Pharmaceuticals Inc share price of $1.21 per share as on September 13, 2025 at 1:29 am IST.

What is the minimum amount required to buy Citius Pharmaceuticals Inc Stock (CTXR) from India?

Indian investors can start investing in Citius Pharmaceuticals Inc (CTXR) shares with as little as ₹88.27 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹882.70 in Citius Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Citius Pharmaceuticals Inc share’s latest price of $1.21 as on September 13, 2025 at 1:29 am IST, you will get 8.2645 shares of Citius Pharmaceuticals Inc. Learn more about fractional shares .

What are the returns that Citius Pharmaceuticals Inc has given to Indian investors in the last 5 years?

Citius Pharmaceuticals Inc stock has given -95.25% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?